Loss of duplexmiR-223 (5p and 3p) aggravates myocardial depression and mortality in polymicrobial sepsis

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1842, Issue 5, 2014, Pages 701-711

  Wang, Xiaohong ^a   Huang, Wei ^a   Yang, Yang ^a   Wang, Yigang ^a   Peng, Tianqing ^b   Chang, Jiang ^c   Caldwell, Charles C ^a   Zingarelli, Basilia ^d   Fan, Guo Chang ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

^c Texas A and M College of Medicine   (United States)

^d CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Inflammation; MicroRNA; Myocardial depression; Sema3A; Sepsis

Indexed keywords

INFLAMMATION; MICRORNA; MYOCARDIAL DEPRESSION; SEMA3A; SEPSIS;

ANIMALS; BASE SEQUENCE; COINFECTION; DNA PRIMERS; FEMALE; HEART; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICRORNAS; REAL-TIME POLYMERASE CHAIN REACTION; SEPSIS;

EID: 84894527235     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2014.01.012     Document Type: Article

References (43)

1. Lever A., Mackenzie I. Sepsis: definition, epidemiology, and diagnosis. BMJ 2007, 335:879-883.
2. Iskander K.N., Osuchowski M.F., Stearns-Kurosawa D.J., Kurosawa S., Stepien D., Valentine C., Remick D.G. Sepsis: multiple abnormalities, heterogeneous responses, and evolving understanding. Physiol. Rev. 2013, 93:1247-1288.
3. Russell J.A., Walley K.R. Update in sepsis 2012. Am. J. Respir. Crit. Care Med. 2013, 187:1303-1307.
4. Dombrovskiy V.Y., Martin A.A., Sunderram J., Paz H.L. Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003. Crit. Care Med. 2007, 35:1244-1250.
5. Romero-Bermejo F.J., Ruiz-Bailen M., Gil-Cebrian J., Huertos-Ranchal M.J. Sepsis-induced cardiomyopathy. Curr. Cardiol. Rev. 2011, 7:163-183.
6. Hochstadt A., Meroz Y., Landesberg G. Myocardial dysfunction in severe sepsis and septic shock: more questions than answers?. J. Cardiothorac. Vasc. Anesth. 2011, 25:526-535.
7. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
8. Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136:215-233.
9. Sayed D., Abdellatif M. MicroRNAs in development and disease. Physiol. Rev. 2011, 91:827-887.
10. Zhu H., Fan G.C. Extracellular/circulating microRNAs and their potential role in cardiovascular disease. Am. J. Cardiovasc. Dis. 2011, 1:138-149.
11. Zhu H., Fan G.C. Role of microRNAs in the reperfused myocardium towards post-infarct remodelling. Cardiovasc. Res. 2012, 94:284-292.
12. Wang L., Wang H.C., Chen C., Zeng J., Wang Q., Zheng L., Yu H.D. Differential expression of plasma miR-146a in sepsis patients compared with non-sepsis-SIRS patients. Exp. Ther. Med. 2013, 5:1101-1104.
13. Roderburg C., Luedde M., Vargas Cardenas D., Vucur M., Scholten D., Frey N., Koch A., Trautwein C., Tacke F., Luedde T. Circulating microRNA-150 serum levels predict survival in patients with critical illness and sepsis. PLoS One 2013, 8:e54612.
14. Wang H., Zhang P., Chen W., Feng D., Jia Y., Xie L.X. Evidence for serum miR-15a and miR-16 levels as biomarkers that distinguish sepsis from systemic inflammatory response syndrome in human subjects. Clin. Chem. Lab. Med. 2012, 50:1423-1428.
15. Wang H., Zhang P., Chen W., Feng D., Jia Y., Xie L. Serum microRNA signatures identified by Solexa sequencing predict sepsis patients' mortality: a prospective observational study. PLoS One 2012, 7:e38885.
16. Wang J.F., Yu M.L., Yu G., Bian J.J., Deng X.M., Wan X.J., Zhu K.M. Serum miR-146a and miR-223 as potential new biomarkers for sepsis. Biochem. Biophys. Res. Commun. 2010, 394:184-188.
17. Wang H., Meng K., WJ Chen, Feng D., Jia Y., Xie L. Serum miR-574-5p: a prognostic predictor of sepsis patients. Shock 2012, 37:263-267.
18. Wang X., Zhu H., Zhang X., Liu Y., Chen J., Medvedovic M., Li H., Weiss M.J., Ren X., Fan G.C. Loss of the miR-144/451 cluster impairs ischaemic preconditioning-mediated cardioprotection by targeting Rac-1. Cardiovasc. Res. 2012, 94:379-390.
19. Wang X., Zhang X., Ren X.P., Chen J., Liu H., Yang J., Medvedovic M., Hu Z., Fan G.C. MicroRNA-494 targeting both proapoptotic and antiapoptotic proteins protects against ischemia/reperfusion-induced cardiac injury. Circulation 2010, 122:1308-1318.
20. Zhang X., Wang X., Zhu H., Zhu C., Wang Y., Pu W.T., Jegga A.G., Fan G.C. Synergistic effects of the GATA-4-mediated miR-144/451 cluster in protection against simulated ischemia/reperfusion-induced cardiomyocyte death. J. Mol. Cell. Cardiol. 2010, 49:841-850.
21. Ren X.P., Wu J., Wang X., Sartor M.A., Qian J., Jones K., Nicolaou P., Pritchard T.J., Fan G.C. MicroRNA-320 is involved in the regulation of cardiac ischemia/reperfusion injury by targeting heat-shock protein 20. Circulation 2009, 119:2357-2366.
22. Haneklaus M., Gerlic M., O'Neill L.A., Masters S.L. miR-223: infection, inflammation and cancer. J. Intern. Med. 2013, 274:215-226.
23. Fulci V., Scappucci G., Sebastiani G.D., Giannitti C., Franceschini D., Meloni F., Colombo T., Citarella F., Barnaba V., Minisola G., Galeazzi M., Macino G. MiR-223 is overexpressed in T-lymphocytes of patients affected by rheumatoid arthritis. Hum. Immunol. 2010, 71:206-211.
24. Dorhoi A, et al. MicroRNA-223 controls susceptibility to tuberculosis by regulating lung neutrophil recruitment. J Clin Invest. 2013 Oct 1. doi:pii: 67604. 0.1172/JCI67604. [Epub ahead of print].
25. Zhuang G., Meng C., Guo X., Cheruku P.S., Shi L., Xu H., Li H., Wang G., Evans A.R., Safe S., Wu C., Zhou B. A novel regulator of macrophage activation: miR-223 in obesity-associated adipose tissue inflammation. Circulation 2012, 125:2892-2903.
26. Johnnidis J.B., Harris M.H., Wheeler R.T., Stehling-Sun S., Lam M.H., Kirak O., Brummelkamp T.R., Fleming M.D., Camargo F.D. Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature 2008, 451:1125-1129.
27. Celes M.R., Torres-Dueñas D., Malvestio L.M., Blefari V., Campos E.C., Ramos S.G., Prado C.M., Cunha F.Q., Rossi M.A. Disruption of sarcolemmal dystrophin and beta-dystroglycan may be a potential mechanism for myocardial dysfunction in severe sepsis. Lab. Invest. 2010, 90:531-542.
28. Li C., Hua F., Ha T., Singh K., Lu C., Kalbfleisch J., Breuel K.F., Ford T., Kao R.L., Gao M., Ozment T.R., Williams D.L. Activation of myocardial phosphoinositide-3-kinase p110α ameliorates cardiac dysfunction and improves survival in polymicrobial sepsis. PLoS One 2012, 7:e44712.
29. Wang X., Zingarelli B., O'Connor M., Zhang P., Adeyemo A., Kranias E.G., Wang Y., Fan G.C. Overexpression of Hsp20 prevents endotoxin-induced myocardial dysfunction and apoptosis via inhibition of NF-kappaB activation. J. Mol. Cell. Cardiol. 2009, 47:382-390.
30. Fan G.C., Ren X., Qian J., Yuan Q., Nicolaou P., Wang Y., Jones W.K., Chu G., Kranias E.G. Novel cardioprotective role of a small heat-shock protein, Hsp20, against ischemia/reperfusion injury. Circulation 2005, 111:1792-1799.
31. Maass D.L., White J., Horton J.W. IL-1beta and IL-6 act synergistically with TNF-alpha to alter cardiac contractile function after burn trauma. Shock 2002, 18:360-366.
32. Zhang H., Wang H.Y., Bassel-Duby R., Maass D.L., Johnston W.E., Horton J.W., Tao W. Role of interleukin-6 in cardiac inflammation and dysfunction after burn complicated by sepsis. Am. J. Physiol. Heart Circ. Physiol. 2007, 292:H2408-H2416.
33. Chen Q., Wang H., Liu Y., Song Y., Lai L., Han Q., Cao X., Wang Q. Inducible microRNA-223 down-regulation promotes TLR-triggered IL-6 and IL-1β production in macrophages by targeting STAT3. PLoS One 2012, 7:e42971.
34. Kimura K., Ieda M., Fukuda K. Development, maturation, and transdifferentiation of cardiac sympathetic nerves. Circ. Res. 2012, 110:325-336.
35. Ieda M., Kanazawa H., Kimura K., Hattori F., Ieda Y., Taniguchi M., Lee J.K., Matsumura K., Tomita Y., Miyoshi S., Shimoda K., Makino S., Sano M., Kodama I., Ogawa S., Fukuda K. Sema3a maintains normal heart rhythm through sympathetic innervations patterning. Nat. Med. 2007, 13:604-612.
36. Wen H., Lei Y., Eun S.Y., Ting J.P. Plexin-A4-semaphorin 3A signaling is required for Toll-like receptor- and sepsis-induced cytokine storm. J. Exp. Med. 2010, 207:2943-2957.
37. Rudiger A., Singer M. The heart in sepsis: from basic mechanisms to clinical management. Curr. Vasc. Pharmacol. 2013, 11:187-195.
38. Martin C., Viviand X., Arnaud S., Vialet R., Rougnon T. Effects of norepinephrine plus dobutamine or norepinephrine alone on left ventricular performance of septic shock patients. Crit. Care Med. 1999, 27:1708-1713.
39. Joulin O., Petillot P., Labalette M., Lancel S., Neviere R. Cytokine profile of human septic shock serum inducing cardiomyocyte contractile dysfunction. Physiol. Res. 2007, 56:291-297.
40. Atefi G., Zetoune F.S., Herron T.J., Jalife J., Bosmann M., Al-Aref R., Sarma J.V., Ward P.A. Complement dependency of cardiomyocyte release of mediators during sepsis. FASEB J. 2011, 201(25):2500-2508.
41. De Jonghe B., Lacherade J.C., Durand M.C., Sharshar T. Critical illness neuromuscular syndromes. Neurol. Clin. 2008, 26:507-520.
42. Bauernfeind F., Rieger A., Schildberg F.A., Knolle P.A., Schmid-Burgk J.L., Hornung V. NLRP3 inflammasome activity is negatively controlled by miR-223. J. Immunol. 2012, 189:4175-4181.
43. Lu H., Buchan R.J., Cook S.A. MicroRNA-223 regulates Glut4 expression and cardiomyocyte glucose metabolism. Cardiovasc. Res. 2010, 86:410-420.